UL - Ben & Jerry's Co-Founders Not Worried About Ozempic's Impact On Ice Cream Business: Here's Why | Benzinga
Ben Cohen and Jerry Greenfield, the co-founders of Ben & Jerry’s, are not worried about the impact of weight-loss drugs on their ice cream business, despite the impending spin-off of their parent company Unilever plc‘s (NYSE:UL) ice cream division.
What Happened: The duo, both 73, believe that people’s relationship with ice cream is more about enjoyment and celebration than nutrition, reported The Wall Street Journal.
This comes at a time when pharmaceutical companies like Eli Lilly And Co (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) are introducing weight-loss drugs like Ozempic and Zepbound, raising concerns about a potential decline in ice cream consumption.
Greenfield says people’s relationship with ice cream is centered on enjoyment and celebration rather than nutrition. Nonetheless, he advises that ice cream should be consumed ...